Passage Bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.63
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
7
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.79
|
-0.49
|
0.30
|
37.97%
|
|
2022-06-30
|
-0.83
|
-0.73
|
0.10
|
12.05%
|
|
2022-03-31
|
-0.89
|
-0.79
|
0.10
|
11.24%
|
|
2021-12-31
|
-0.89
|
-0.95
|
-0.06
|
-6.74%
|
|
2021-09-30
|
-0.86
|
-0.87
|
-0.01
|
-1.16%
|
|
2021-06-30
|
-0.76
|
-0.90
|
-0.14
|
-18.42%
|
|
2021-03-31
|
-0.74
|
-0.76
|
-0.02
|
-2.70%
|
|
2020-12-31
|
-0.70
|
-0.85
|
-0.15
|
-21.43%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.01
|
|
2021-12-31
|
-3.48
|
|
2020-12-31
|
-3.08
|
|
2019-12-31
|
-0.69
|